ABT-491 Hydrochloride - CAS 189689-94-9
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
ABT-491 Hydrochloride
Catalog Number:
189689-94-9
Synonyms:
4-ethynyl-3-[3-fluoro-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzoyl]-N,N-dimethylindole-1-carboxamide;hydrochloride; ABT 491; ABT-491
CAS Number:
189689-94-9
Description:
ABT-491 Hydrochloride is a potent, selective and orally active platelet-activating factor receptor (PAF-R) antagonist (Ki = 0.6 nM in human platelets).
Molecular Weight:
515.97
Molecular Formula:
C28H23ClFN5O2
COA:
Inquire
MSDS:
Inquire
Canonical SMILES:
CC1=NC2=C(N1CC3=C(C=C(C=C3)C(=O)C4=CN(C5=CC=CC(=C54)C#C)C(=O)N(C)C)F)C=CN=C2.Cl
InChI:
1S/C28H22FN5O.ClH/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33;/h1,6-14,16H,15H2,2-4H3;1H
InChIKey:
AWRGBOKANQBIBM-UHFFFAOYSA-N
Targets:
Platelet-activating factor receptor (PAF-R)
Chemical Structure
CAS 189689-94-9 ABT-491 Hydrochloride

Related Platelet-activating factor receptor (PAF-R) Products


CAS 189689-94-9 ABT-491 Hydrochloride

ABT-491 Hydrochloride
(CAS: 189689-94-9)

ABT-491 Hydrochloride is a potent, selective and orally active platelet-activating factor receptor (PAF-R) antagonist (Ki = 0.6 nM in human platelets).

ABT-491
(CAS: 170499-15-7)

ABT-491, an imidazopyridine derivative, has been found to be a PAF receptor antagonist that was once studied against allergic rhinitis.

MK 287
(CAS: 135947-75-0)

MK-287 is platelet activating factor (PAF) inhibitor originated by Merck & Co. It can potently inhibit [3H]C18-PAF binding to human platelet, PMN (polymorphonuc...

CAS 122957-06-6 Modipafant

Modipafant
(CAS: 122957-06-6)

This active molecular is a dihydropyridine Platelet-Activating Factor (PAF) antagonist under the development of Pfizer. In Sep 2015, treatment for Asthma in USA...

Aglafoline
(CAS: 143901-35-3)

Aglafoline, isolated from Aglaia elliptifolia Merr, is a selective PAF-induced platelet aggregation inhibitor. And studies have shown that because aglafoline bl...

CAS 15291-76-6 Ginkgolide C

Ginkgolide C
(CAS: 15291-76-6)

Ginkgolide C, extracted from the Ginkgo biloba leaves, a traditional Chinese medicine, significantly increases the formation of cyclic adenosine monophosphate (...

Reference Reading


1.Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH1, Magoc TJ, Tapang P, Luo G, Morgan DW, Curtin M, Sheppard GS, Xu L, Heyman HR, Davidsen SK, Summers JB, Carter GW. Eur J Pharmacol. 1997 Apr 23;325(1):69-80.
ABT-491 (4-ethynyl-N, N-dimethyl-3-[3-fluoro-4-[(2-methyl-1H-imidazo-[4,5-c]pyridin-1-yl)methy l]benzoyl]-1H- indole-1-carboxamide hydrochloride) is a novel PAF (platelet-activating factor) receptor antagonist with a K(i) for inhibiting PAF binding to human platelets of 0.6 nM. Binding kinetics of ABT-491 to the PAF receptor is consistent with a relatively slow off-rate of the antagonist when compared to PAF. Inhibition of PAF binding is selective and is correlated with functional antagonism of PAF-mediated cellular responses (Ca2+ mobilization, priming, and degranulation). Administration of ABT-491 in vivo leads to potent inhibition of PAF-induced inflammatory responses (increased vascular permeability, hypotension, and edema) and PAF-induced lethality. Oral potency (ED50) was between 0.03 and 0.4 mg/kg in rat, mouse, and guinea-pig. When administered intravenously in these species, ABT-491 exhibited ED50 values between 0.005 and 0.016 mg/kg.